Carregant...
Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
Multiple Sclerosis (MS) pathology is complex and includes inflammatory processes, neurodegeneration, and demyelination. While multiple drugs have been developed to tackle MS-related inflammation, to date there is scant evidence regarding which therapeutic approach, if any, could be used to reverse d...
Guardat en:
| Publicat a: | Neurotherapeutics |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722763/ https://ncbi.nlm.nih.gov/pubmed/28695472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0558-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|